NAD+ and NMN: Mitochondrial Energy, Sirtuin Activation, and Skin Aging at the Cellular Level

This article is for informational purposes only and does not constitute medical advice. Always consult your dermatologist, physician, or healthcare provider before starting any supplement, especially if you have a skin condition or take medications. Dietary supplements are not evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.

HathawayMD.com Editorial Team | July 2026

NAD+ and NMN: Mitochondrial Energy, Sirtuin Activation, and Skin Aging at the Cellular Level

NAD+ (nicotinamide adenine dinucleotide) is a critical coenzyme in cellular energy metabolism and a key substrate for sirtuins—proteins that regulate aging pathways and cellular stress responses. As we age, NAD+ levels decline by up to 50% by age 60, and this depletion is mechanistically linked to skin aging, compromised barrier function, and reduced fibroblast collagen production. NMN (nicotinamide mononucleotide), a NAD+ precursor, has emerged as a promising supplement to restore NAD+ levels and theoretically slow skin aging at a fundamental cellular level. Clinical evidence in humans for skin-specific benefits is still emerging, but animal and mechanistic data are compelling.

Cellular Biochemistry: NAD+ Depletion and Skin Aging

NAD+ serves two critical functions: as a coenzyme in mitochondrial energy production (ATP synthesis) and as a substrate for sirtuins (SIRT1-7), proteins that regulate autophagy, DNA repair, inflammation, and metabolic adaptation. During aging and UV exposure, NAD+ levels drop. Simultaneously, sirtuins become less active, leading to accumulation of cellular damage, reduced autophagy (the cell's self-cleaning mechanism), and accelerated senescence (cellular aging).

In skin specifically, NAD+ depletion correlates with reduced fibroblast collagen synthesis, increased keratinocyte senescence (dead cells that don't turn over properly), and compromised barrier lipid production. This creates a cascade: less energy → less collagen → less barrier → more inflammation → more aging.

NMN (nicotinamide mononucleotide) is a NAD+ precursor—one step closer to NAD+ than nicotinamide itself. When ingested, NMN is theoretically absorbed and converted to NAD+ in cells, restoring the NAD+ pool and reactivating sirtuin-dependent anti-aging pathways.

Current Research on NAD+ and Skin Aging

Animal Model Evidence: Extensive research in mouse models of aging shows that NMN supplementation increases dermal NAD+ levels by 30-50%, enhances fibroblast collagen production, improves skin barrier function, and delays visible aging phenotypes (wrinkles, laxity, pigmentation). These studies are mechanistically robust but cannot be directly extrapolated to human skin.

Human Clinical Evidence (Emerging): Human NMN trials for skin are limited. A 12-week open-label trial in 30 postmenopausal women taking 250 mg NMN daily found subjective improvement in skin elasticity and hydration, with biomarker improvements in skin hydration (corneometry) and elasticity (cutometry) of 15-20%. Dermal NAD+ levels were not directly measured. Evidence Level: Preliminary.

NAD+ Biomarker Studies: Some research shows that oral NMN increases circulating NAD+ levels or NAD+ metabolites in humans, but whether this translates to sufficient dermal NAD+ restoration to meaningfully impact skin aging remains unproven in controlled clinical trials.

Mitochondrial Function and Senescence: In vitro studies show NMN restores mitochondrial function in aged fibroblasts and reduces cellular senescence markers. These are compelling mechanistic proofs-of-concept but do not confirm visible skin anti-aging in humans.

Critical Limitation: Human skin aging is multifactorial (genetics, sun exposure, inflammation, lifestyle). NAD+ depletion is one contributing factor, not the sole driver. Restoring NAD+ in one pathway may not produce clinically visible improvements if other aging mechanisms are unaddressed.

Dose and Bioavailability Considerations

Clinical trials used 250-1000 mg NMN daily. Bioavailability is modest—most oral NMN is metabolized rapidly; only a fraction reaches circulation as active NAD+. Time-release formulations marketed as “enhanced bioavailability” lack rigorous comparative data.

Duration of use in human trials was 12 weeks minimum. Shorter supplementation is unlikely to show benefits. Many manufacturers recommend 8-12 week courses followed by reassessment.

Cost is high: quality NMN supplements are $80-150/month for effective doses. This makes long-term supplementation costly relative to other skin anti-aging strategies.

NAD+ Precursors: NMN vs. NR vs. Nicotinamide

NMN (nicotinamide mononucleotide): More expensive, theoretically more direct route to NAD+ restoration, limited but promising human evidence.

NR (nicotinamide riboside): Similar mechanism to NMN, slightly cheaper, similar limited human data for skin.

Nicotinamide (Vitamin B3): Cheaper, abundant, has solid dermatological evidence for skin barrier repair and sebum regulation (see Niacinamide profile). Does not directly restore NAD+ as efficiently as NMN but may support baseline NAD+ metabolism.

Practical recommendation: If budget is limited, niacinamide (cheaper, proven) is a more evidence-supported choice than NMN. NMN makes sense for those willing to invest in an emerging, mechanistically intriguing intervention with modest preliminary human evidence.

Combining NAD+ Boosters with Other Anti-Aging Strategies

NAD+ restoration theoretically complements other anti-aging approaches—retinoids, vitamin C, peptides—because it addresses energy and autophagy at a fundamental level. No trials directly compare combined approaches, but mechanistically they should be synergistic. Some practitioners recommend combining NMN with resveratrol (a sirtuin activator) or sirtuinogenic compounds (compounds that activate sirtuins), though this is highly speculative.

Calorie restriction, intermittent fasting, and exercise are all known to boost NAD+ and sirtuin activity—and their skin anti-aging benefits are better documented than NMN supplementation alone. Lifestyle optimization may be more impactful than supplementation.

Safety, Interactions, and Contraindications

General Safety Profile: NMN has been tested in human trials with minimal adverse events reported. Common mild effects: GI distress, headache, fatigue (rare).

Cancer Risk Theoretical Concern: Some animal studies suggest that very high NAD+ levels could theoretically promote cancer cell growth (NAD+ fuels proliferation). This remains theoretical and unproven in humans, but patients with cancer history should consult their oncologist before using NAD+ precursors.

Immunosuppression: Some sirtuins modulate immune function. Immunocompromised patients or those on immunosuppressive medications should consult their physician.

Drug Interactions: None well-documented, but NAD+ is involved in metabolism of many drugs. Patients on multiple medications should discuss with their pharmacist.

Pregnancy/Lactation: Limited safety data. Most practitioners recommend avoiding NMN during pregnancy and breastfeeding.

Who Is a Good Candidate for NAD+ Supplementation

Reasonable Candidates: Aging adults (45+) interested in cutting-edge skin anti-aging science; individuals with significant photoaging or skin laxity seeking to address aging at a mitochondrial level; those interested in systemic longevity benefits beyond skin (NAD+ has implications for muscle, brain, metabolic health).

Who Should Avoid or Use Cautiously: Patients with active or history of cancer (theoretical concern); pregnant/nursing individuals; patients on complex medication regimens; those on immunosuppressive therapies. Those with limited budgets should prioritize proven interventions (retinoids, vitamin C, sunscreen) before NMN.

Realistic Expectations: NAD+ supplementation is speculative for skin aging in humans. Animal data and mechanistic reasoning are compelling, but human clinical evidence is minimal. Visible skin improvement is unlikely to match that of retinoids, peptides, or vitamin C. This is a “future medicine” intervention—scientifically plausible but clinically unproven for skin outcomes.

Clinical Bottom Line

NAD+ restoration via NMN supplementation represents a mechanistically compelling but clinically unproven approach to skin aging. The science is sound—NAD+ depletion is a feature of aging, and restoring NAD+ does promote anti-aging pathways in animal models. However, human evidence for visible skin benefits is preliminary at best. NAD+ precursors are expensive and unproven in dermatology. They may eventually become standard anti-aging tools, but currently, they should be viewed as an experimental add-on for those interested in longevity science, not as a primary skin anti-aging strategy. Lifestyle optimization (calorie restriction, exercise, sleep) may provide equivalent or superior NAD+ benefits at zero cost.

This ingredient profile is provided for educational purposes only. It does not constitute medical advice, a treatment recommendation, or a substitute for evaluation by a qualified dermatologist, physician, or healthcare provider. Patients with skin conditions should discuss all supplement use with their dermatology care team before starting, stopping, or changing any supplement. Individual responses to supplements vary significantly based on skin type, age, sun exposure history, and concurrent treatments. HathawayMD.com is an independent editorial publication and is not affiliated with any hospital, clinic, dermatology practice, or medical provider.